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 Abstract 
Kate Rae Oppegaard 
Gender Differences in the Use of Engagement and Disengagement Coping Strategies in 
Oncology Patients Receiving Chemotherapy 
The purpose of this study, in a sample of women (n=277) and men (n=293) undergoing 
chemotherapy for either gastrointestinal or lung cancer, was to evaluate for gender differences in 
coping strategies using the Brief COPE. While approximately equal numbers of women and men 
will be diagnosed with lung and colorectal cancer, women have been underrepresented in both 
lung and gastrointestinal cancer research. Regardless of cancer site, men have been 
underrepresented in studies that focus on psychosocial issues associated with a cancer diagnosis 
and its treatment. This unequal representation of both sexes leaves significant gaps in our 
knowledge of differences in the way that women and men cope with the diagnosis and treatments 
associated with lung or GI cancers (i.e., two cancers that have equal occurrence rates in both 
genders). This analysis is part of a larger study that evaluated the symptom experience of 
outpatients receiving chemotherapy. Patients were recruited from two Comprehensive Cancer 
Centers, one Veteran’s Affairs hospital, and four community-based oncology programs. Coping 
data was obtained using the Brief COPE from patients with gastrointestinal (n=412) and lung 
(n=158) cancer. Gender was identified by self-report. In terms of the use of engagement coping 
strategies, women reported higher scores for positive reframing, religion, and using instrumental 
support. Men reported higher scores for humor. In terms of the use of disengagement coping 
strategies, women reported higher scores for denial, venting and self-distraction. Men reported 
higher scores for substance use.  
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INTRODUCTION 
While approximately equal numbers of women and men will be diagnosed with lung and 
colorectal cancers,1 women have been under-represented in both lung and gastrointestinal (GI) 
cancer research.2 In contrast, regardless of cancer site, men have been underrepresented in 
studies that focus on psychosocial issues associated with a cancer diagnosis and its treatment.2 
This unequal representation of both sexes leaves significant gaps in our knowledge of differences 
in the way that women and men cope with the diagnosis and treatments associated with lung or 
GI cancers (i.e., two cancers that have equal occurrence rates in both genders). Previous research 
found that the use of specific coping strategies influences the amount of distress oncology 
patients experience3 and directly impacts their quality of life (QOL).4 An evaluation of gender 
differences in the use of various coping strategies may provide insights that can be used by 
clinicians to educate patients about more positive coping strategies, as well as develop more 
tailored interventions, and/or make appropriate referrals to support services.  
Both women and men can experience short-term and long-term stress related to cancer 
and its treatments that necessitates an ongoing need to adapt and cope.5 According to Lazarus’ 
Cognitive Appraisal Theory,6 individuals stress when they perceive that they are unable to 
adequately respond to life’s demands. Individuals come to this conclusion through a series of 
appraisals. Primary appraisal involves making a decision if the stressor poses a threat. Secondary 
appraisal involves using one’s coping behaviors to respond to the threat and reappraisal 
combines both primary and secondary appraisals to adapt to the stressor. Most coping strategies 
that are used to respond to stressors can be grouped into engagement and disengagement 
categories. Engagement coping strategies utilize more direct approaches to deal with or reduce 
  
stress and are typically associated with a more adaptive responses. In contrast, disengagement 
coping strategies tend to be viewed as more avoidant and maladaptive.7 
Only four studies were identified that evaluated for gender differences in coping with 
cancer.8-11 In a United States study that evaluated 208 women and 125 men with a variety of 
cancer diagnoses (i.e., breast, testicular, lymphoma, lung) and assessed for differences in their 
coping styles using the Ways of Coping Checklist,8 the investigators found that compared to 
men, women used religion, social support, active coping, and positive focusing more frequently. 
In contrast, men used avoidance coping more frequently. In the second study of Israeli women 
(n=153) and men (n=186) with colorectal cancer,9 the Mental Adjustment to Cancer (MAC) 
scale was used to asses gender differences in coping styles. Compared to men, women used a 
fighting spirit style of coping more often. In contrast, men were more likely to use a 
hopelessness/helplessness style or a fatalistic acceptance style of coping. 
In the third qualitative study from the United Kingdom,10 gender differences in the 
experiences of 14 women and 24 men with colorectal cancer were evaluated. Women were less 
likely than men to downplay their long-term symptoms or side effects. Of note, some men 
reported embarrassment or negativity with showing emotions. In the fourth study done in the 
United States,11 47 women and 53 men with lung cancer completed the Coping Effectiveness 
Scale and the religious coping subscale of the Fetzert/National Institute on Aging Brief 
Multidimensional Measure of Religiousness/Spirituality. While no differences were found in 
coping effectiveness, women used religious forms of coping more frequently than men. 
While these four studies provide some insights into gender differences in coping with 
cancer, several limitations warrant consideration. Sample sizes for two of the studies were very 
small.10, 11 The methods used to obtain information on biological sex and/or gender were not 
  
reported. Across the four studies,8-11 the measures used to assess coping were inconsistent and 
none of the studies used the most commonly used instrument to assess coping in oncology 
patients, namely the Brief COPE.12, 13 Given the limited amount of research on gender differences 
in coping with cancer, the purpose of this study, in a sample of women (n=277) and men (n=293) 
undergoing chemotherapy (CTX) for either GI or lung cancer, was to evaluate for gender 
differences in coping strategies using the Brief COPE.14 
PATIENTS AND METHODS 
Patients and Settings 
This analysis is part of a larger, longitudinal study, that evaluated the symptom 
experience of oncology outpatients receiving CTX. Detailed methods for the parent study can be 
found elsewhere.15 In brief, eligible patients were ≥18 years of age; had a diagnosis of a GI, 
breast, gynecological, or lung cancer; had received CTX within the preceding four weeks; were 
scheduled to receive at least two additional cycles of CTX; were able to read, write, and 
understand English; and gave written informed consent. Patients were recruited from two 
Comprehensive Cancer Centers, one Veteran’s Affairs hospital, and four community-based 
oncology programs. Of the 2234 patients approached, 1343 consented to participate (60.1% 
response rate). The major reason for refusal was being overwhelmed with their cancer treatment. 
Of the 1343 patients in the parent study, data from 570 patients with GI (n=412) and lung 
(n=158) cancer were used in this analysis. This sample was selected because GI and lung cancers 
occur equally among women and men.  
 
 
 
  
Instruments 
Patients completed a demographic questionnaire, the Alcohol Use Disorders 
Identification Test (AUDIT),16, 17 the Karnofsky Performance Status (KPS) scale,18 and the Self-
Administered Comorbidity Questionnaire (SCQ).19  
The 28-item Brief COPE scale was designed to assess a broad range of coping responses 
among adults with a variety of medical conditions.14 Each item was rated on a four-point Likert 
scale that ranged from 1 (I haven’t been doing this at all) to 4 (I have been doing this a lot). 
Higher scores indicate greater use of the various coping strategies. In total, 14 strategies are 
evaluated using this instrument (with their respective Cronbach alphas), namely: self-distraction 
(0.46), active coping (0.75), denial (0.72), substance use (0.87), use of emotional support (0.77), 
use of instrumental support (0.77), behavioral disengagement (0.57), venting (0.65), positive 
reframing (0.79), planning (0.74), humor (0.83), acceptance (0.68), religion (0.92), and self-
blame (0.73). Each coping strategy is evaluated using two items. The Brief COPE has well 
established validity and reliability in oncology patients. 12, 13 
Study Procedures 
 The study was approved by the Committee on Human Research at the University of 
California, San Francisco and by the Institutional Review Board at each of the study sites. 
Eligible patients were approached by a research staff member in the infusion unit during their 
first or second cycle of CTX to discuss participation in the study. Written informed consent was 
obtained from all patients. Medical records were reviewed for disease and treatment information.  
Data Analysis 
Data from the enrollment assessment (i.e., the week prior to the initiation of the patients’ 
second or third cycle of CTX) were analyzed using SPSS version 22 (IBM, Armonk, NY). 
  
Descriptive statistics and frequency distributions were calculated for the demographic and 
clinical characteristics. Gender differences in the use of various coping strategies were evaluated 
using Independent sample t-tests, Chi Square analyses, and Mann Whitney U-tests. A p-value of 
<0.05 was considered statistically significant. Effect size calculations were done (i.e., Cohen’s d) 
to evaluate for clinically meaningful differences in the use of various coping strategies by 
women and men. Effect sizes of 0.2 to 0.5 are considered small, >0.5 to 0.8 are moderate, and 
>0.8 are large.20 
RESULTS 
Demographic characteristics  
Of the 570 patients, 48.6% were female and 51.4% were male (Table 1). Gender was 
identified by patient self-report from the options male, female, or transgender. Biological sex 
was identified through genomic analysis and matched to self-reports of gender for all of the 
patients. While this study evaluated both biological sex and gender, we will use the term gender 
to contextualize differences between women and men. Compared to the males, females were 
significantly younger, were less likely to be employed, and reported a lower annual household 
income. In addition, females had a lower body mass index (BMI), a higher number of comorbid 
conditions, a higher SCQ score, a lower functional status score, a lower hemoglobin and 
hematocrit, a lower AUDIT score, were less likely to exercise on a regular basis, and were more 
likely to have lung cancer.  
Gender differences in the use of coping strategies  
 As shown in Table 2, compared to males, females reported significantly greater use of six 
of the 14 coping strategies assessed by the Brief COPE, i.e., positive reframing (p = 0.020), 
religion (p < 0.001), instrumental support (p = 0.007), self-distraction (p = 0.006), denial (p = 
  
0.001), and venting (p < 0.001). In contrast, males reported higher use of humor (p = 0.032), and 
substance use (p < 0.001). In contrast, no significant gender differences were found in self-
reported use of active coping, planning, acceptance, emotional support, behavioral 
disengagement, and self-blame. For the subscale scores of the Brief COPE that demonstrated 
significant differences, effect sizes ranged from 0.18 (i.e., humor) to 0.35 (i.e., venting).  
DISCUSSION   
This study is the first to evaluate for gender differences in the use of coping strategies in 
a large sample of patients receiving CTX for GI or lung cancer using the Brief COPE. Of note, 
compared to other studies of patients with cancer that used the Brief COPE,12, 21, 22 our patients’ 
scores for use of each of the strategies were similar. In terms of the engagement coping strategies 
that demonstrated gender differences, females had higher scores for positive reframing, religion, 
and using instrumental support, while males had higher scores for humor. In terms of 
disengagement coping strategies that demonstrated gender differences, females had higher scores 
for self-distraction, denial and venting, while males had higher scores for substance use. 
Consistent with a previous report,8 women in our study were more likely than men to use 
positive reframing (d= 0.20). Positive reframing has been shown to decrease feelings of 
depression and allow for stressful situations to be redefined as less stressful.23 Of note, in one 
study of men with prostate cancer,24 positive reframing was a coping characteristic associated 
with the development of positive feelings. In another study of patients with breast cancer,25 
women reported that positive reframing served as a beneficial coping strategy. 
Again, consistent with previous studies,8, 11 women in our study reported more frequent 
use of religious coping (d= 0.31). Previous research has identified religion as a positive coping 
mechanism for females with breast cancer26 and males with prostate cancer.24, 27, 28 Religious 
  
coping during cancer is dynamic and is used by individuals differently (e.g., to facilitate 
closeness with a god, for spiritual connection with others, for comfort, to make meaning of the 
cancer experience).29 
Consistent with previous research,8 the women in our study reported higher use of 
instrumental support (d= 0.23). The Brief Cope assesses instrumental support by asking patients 
to rate how often they are “getting help or advice from other people”.14 Most patients with 
cancer, regardless of gender, will need some amount of instrumental support, as treatment plans 
are often lengthy and complex.30 With that in mind, traditional views of masculinity as it relates 
to help-seeking could account for the gender differences in the scores for the use of this 
strategy.31 
The only engagement coping strategy that had higher scores in males was the use of 
humor (d= -0.18). A concept analysis of the use of humor in the context of adults with cancer 
found that humor helped patients positively cope with their situations, as well as facilitated 
closeness between the patient and nurse.32 
While females in our study reported higher scores for the use of self-distraction, these 
results were not identified, previously. Self-distraction is a form of disengagement coping that 
has been associated with decreased self-esteem, fewer functional relationships, and decreased 
meaning in life in both women and men with cancer.33 However, similar to other forms of 
disengagement coping, self-distraction may have some adaptive utility.34 
While in our study, females reported higher scores for denial (d= 0.29), previous research 
that evaluated for associations between gender and the use of denial as a coping strategy in 
oncology patients yielded inconclusive findings.35 Denial can be viewed as either a maladaptive 
or adaptive response depending on how it is used and its utility in dealing with illness is debated 
  
in the literature.35 However, evidence suggests that denial can lead to worse outcomes (e.g., delay 
in seeking care and in getting treatment) and decreases in oncology patients’ survival.36 
Given that previous reports found that men are less likely to express emotions through 
venting,10, 37 it is not surprising that females in our study reported higher scores for this coping 
strategy (d= 0.35). While in one study,38 the use of venting was shown to perpetuate negative 
emotions, in other studies it provided an avenue to enlist needed social support.39, 40 
While no studies were found on gender differences in substance use as a coping strategy 
in patients with cancer, in our study, males reported higher scores for this subscale (d= -0.27). In 
a recent systematic review,41 substance use was present in 2% to 35% of oncology patients and 
these rates have remained relatively stable from 1995 to 2018. Substance use can lead to less 
desirable outcomes because of its negative effects on physical and emotional health; its potential 
to create barriers to treatment adherence; and its potential to impact pain tolerance.42 
Furthermore, in a meta-analysis of coping strategies used by men with prostate cancer, men who 
coped in ways that did not allow them to face their cancer “head on” experienced more physical 
and emotional pain.43 
While coping with cancer has been studied extensively,43, 44 much of the literature 
provides information on sex-specific cancers.2 In our large sample of patients with GI and lung 
cancers, the use of a number of coping strategies did, in fact, differ between women and men. It 
is worth noting that compared to males, females had higher scores for three types of 
disengagement coping (i.e., denial, venting, self-distraction), all of which have been correlated 
with higher levels of distress in patients with cancer.45 Males reported a higher score for the 
disengagement coping strategy of substance use, which suggests not only that men are more 
likely to utilize substances to cope, but that they may be more vulnerable to their negative 
  
consequences. Clinicians can use these findings to assess patients’ use of various coping 
strategies, as well as reinforce more positive ones and intervene on more negative ones through 
appropriate referrals.  
Gender is constructed by a variety of cultural, political, and social norms46 and has an 
influence on the way that people cope with various stressors, as well as on their health 
outcomes.47 Gender-based stereotypes of emotional expression may impact how women and men 
express themselves and the ways in which support is offered to them by others.37 These nuances 
could account for some of the differences in our patients’ scores. With these findings in mind, 
clinicians should be more aware of their own preconceived notions about sex and gender and 
reflect on how these stereotypes may influence the psychosocial care they provide to oncology 
patients.  
Several limitations should be noted. First, the major reason for refusal to participate in 
this study was being overwhelmed with cancer treatment, which suggests a missed opportunity to 
measure coping strategies in patients who may be experiencing higher levels of stress. In 
addition, coping was assessed at only one point in the treatment trajectory. Future research needs 
to evaluate whether gender differences in the use of various coping strategies change throughout 
the course of cancer treatment and into survivorship. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1 – Gender Differences in Demographic and Clinical Characteristics 
 
Characteristic Females 
48.6% (n=277) 
Males  
51.4% (n=293) 
Statistics 
 Mean (SD) Mean (SD) 
Age (years) 58.5 (12.2) 61.1 (11.5) t = -2.61, p = .009 
Education (years) 15.9 (3.2) 16.2 (3.1) t = -0.87, p = .381 
Body mass index (kg/m2) 24.9 (5.5) 26.3 (4.5) t = -3.19, p = .002 
Karnofsky Performance Status score 78.0 (13.1) 82.3 (12.3) t = -3.98, p < .001 
Number of comorbid conditions 2.8 (1.6) 2.4 (1.4) t = 3.31, p = .001 
Self-administered Comorbidity Questionnaire score 6.4 (3.4) 5.6 (3.2) t = 2.87, p = .004 
AUDIT score 2.4 (2.1) 3.8 (3.0) t = -5.08, p < .001 
Time since diagnosis (years) 1.4 (3.2)  1.4 (2.6) U, p = .463 Time since diagnosis (median; years) 0.41 0.30 
Number of prior cancer treatments 1.5 (1.3) 1.3 (1.4) t = 1.57, p = .118 
Number of metastatic sites including lymph node 
involvement (out of 9) 1.4 (1.1) 1.4 (1.1) t = 0.22, p = .827 
Number of metastatic sites excluding lymph node 
involvement 1.0 (1.0) 0.9 (1.0) t = 0.72, p = .469 
Hemoglobin 11.4 (1.3) 12.2 (1.7) t = -5.95, p < .001 
Hematocrit 34.5 (3.7) 36.5 (4.6) t = -5.63, p < .001 
 % (n) % (n)  
Self-reported ethnicity 
 White 
 Asian or Pacific Islander 
 Black 
 Hispanic, Mixed, or Other  
 
65.8 (179) 
12.1 (33) 
10.7 (29) 
11.4 (31) 
 
71.4 (207) 
12.1 (35) 
7.6 (22) 
9.0 (26) 
Χ2 = 2.92, p = .405 
Married or partnered (% yes) 63.5 (176) 69.7 (202) FE, p= .130 
Lives alone (% yes) 20.2 (56) 20.8 (60) FE, p= .917 
Currently employed (% yes) 26.3 (72) 35.6 (103) FE, p= .018 
Annual household income 
 Less than $30,000 
 $30,000 to $70,000 
 $70,000 to $100,000 
 Greater than $100,000 
 
24.2 (60) 
25.4 (63) 
15.3 (38) 
35.1 (87) 
 
20.0 (53) 
17.7 (47) 
17.4 (46) 
44.9 (119) 
U, p = .015 
Childcare responsibilities (% yes) 21.5 (58) 16.4 (47) FE, p= .130 
Elder care responsibilities (% yes) 7.2 (18) 7.8 (21) FE, p= .868 
Current or past history of smoking (% yes) 39.7 (108) 44.7 (127) FE, p = .264 
Exercise on a regular basis (% yes) 62.4 (169) 71.1 (207) FE, p= .031 
Cancer diagnosis 
 Gastrointestinal cancer 
 Lung cancer 
 
67.9 (188) 
32.1 (89) 
 
76.5 (224) 
23.5 (69) 
FE, p = .025 
Prior cancer treatment 
 No prior treatment 
 Only surgery, CTX, or RT 
 Surgery and CTX, or surgery and RT, or 
 CTX and RT 
 Surgery and CTX and RT 
 
27.6 (74) 
38.8 (104) 
21.3 (57) 
 
12.3 (33) 
 
35.5 (99) 
34.8 (97) 
19.0 (53) 
 
10.8 (30) 
Χ2 = 3.93, p = .270 
Metastatic sites 
 No metastasis 
 Only lymph node metastasis 
 Only metastatic disease in other sites 
 Metastatic disease in lymph nodes and 
 other sites 
19.4 (53) 
20.1 (55) 
32.6 (89) 
27.8 (76) 
20.4 (59) 
18.7 (54) 
27.7 (80) 
33.2 (96) 
Χ2 = 2.68, p = .443 
Cycle length 
 14-day cycle 
 21-day cycle 
 28-day cycle 
 
56.9 (165) 
35.0 (97) 
5.4 (15) 
 
62.0 (181) 
33.2 (97) 
4.8 (14) 
Χ2 = 0.38, p = .827 
Abbreviations: AUDIT = Alcohol Use Disorders Identification Test, CTX = chemotherapy, FE = Fisher’s Exact test, kg = kilograms, m2 
= meters squared, RT = radiation therapy, SD = standard deviation, U = Mann Whitney U test 
 
 
 
  
Table 2 – Gender Differences in the Brief COPE Subscale Scores 
 
Brief COPE Subscales Females 
48.6% (n=277) 
Males 
51.4% (n=293) 
Statistics Cohen’s d  
Mean (SD) Mean (SD) 
Active coping  6.0 (1.7) 5.9 (1.7) t = 0.82, p = .414  
Planning  5.2 (1.8) 5.1 (1.9) t = 1.20, p = .231  
Positive reframing  5.4 (2.0) 5.0 (2.0) t = 2.34, p = .020 0.20 
Acceptance  6.6 (1.5) 6.7 (1.4) t = -0.81, p = .418  
Humor  4.0 (2.0) 4.3 (2.0) t = -2.15, p = .032 -0.18 
Religion  5.1 (2.4) 4.4 (2.3) t = 3.63 p < .001 0.31 
Using emotional support  6.4 (1.6) 6.2 (1.8) t = 1.77, p = .077  
Using instrumental support  5.4 (1.8) 5.0 (1.8) t = 2.71, p = .007 0.23 
Self-distraction  5.5 (1.7) 5.1 (1.8) t = 2.75, p = .006 0.23 
Denial  2.7 (1.3) 2.4 (1.0) t = 3.39, p = .001 0.29 
Venting  4.0 (1.6) 3.5 (1.5) t = 4.07, p < .001 0.35 
Substance use  2.1 (0.6) 2.4 (0.9) t = -3.24, p < .001 -0.27 
Behavioral disengagement  2.3 (0.8) 2.2 (0.7) t = 1.63, p = .104  
Self-blame  2.8 (1.3) 2.7 (1.1) t = 1.85, p = .065  
 
Abbreviations: SD = standard deviation 
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